Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tiotropium + Olodaterol, ATC R03AL06 für die Zeit 01.06.2024 - 31.05.2026
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- Boehringer Ingelheim Pharma GmbH & Co. KG, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, kohlpharma GmbH
- Contract value
- no value published
- Bids received
- 8
- Published
- 28 May 2026
- Awarded
- 1 Jun 2024
- Contract start
- 1 Jun 2024
- Contract end
- 14 Jun 2025estimated
- Region
- Hamburg